scispace - formally typeset
K

Karl E. Krueger

Researcher at Georgetown University

Publications -  32
Citations -  2573

Karl E. Krueger is an academic researcher from Georgetown University. The author has contributed to research in topics: Receptor & Binding site. The author has an hindex of 19, co-authored 32 publications receiving 2538 citations.

Papers
More filters
Journal ArticleDOI

Peripheral-type benzodiazepine receptors mediate translocation of cholesterol from outer to inner mitochondrial membranes in adrenocortical cells.

TL;DR: The current study elucidates the specific step in the steroid biosynthetic pathway by which PBR mediate the stimulation in steroid hormone production and suggests that mitochondrial intermembrane cholesterol transport in steroidogenic cells is mediated by a mechanism coupled to PBR.
Journal ArticleDOI

The peripheral-type benzodiazepine receptor is functionally linked to Leydig cell steroidogenesis.

TL;DR: PBR are implicated in the acute stimulation of Leydig cell steroidogenesis possibly by mediating the entry, distribution, and/or availability of cholesterol within mitochondria.
Journal ArticleDOI

Mitochondrial benzodiazepine receptors regulate steroid biosynthesis.

TL;DR: Results suggest that ligands of the peripheral-type benzodiazepine recognition site acting on this mitochondrial receptor can enhance steroid production, and this action may contribute specificity to the pharmacological profile of drugs preferentially acting on the Benzodiazepines associated with the outer membrane of certain mitochondrial populations.
Journal ArticleDOI

Developmental changes in localization of NMDA receptor subunits in primary cultures of cortical neurons

TL;DR: The data indicate that excitatory synapse formation occurs when NMDA receptors comprise NR1 and NR2B subunits, and that NR2A subunits cluster preferentially at synaptic sites.
Journal ArticleDOI

Diazepam binding inhibitor and its processing products stimulate mitochondrial steroid biosynthesis via an interaction with mitochondrial benzodiazepine receptors.

TL;DR: Flunitrazepam, a benzodiazepine that binds with high nanomolar affinity to MBR, was recently shown to act as an antagonist of ACTH and LH/hCG-induced steroidogenesis and was found in the present studies to inhibit DBI-stimulated mitochondrial steroidogenesis.